Injectable Alpha 1-antitrypsin
| Source | SynBio Database www.halozyme.com |
|---|---|
| Organization | Halozyme |
| Market status | Under Development |
| Industry | Health |
| Value chain stage | Finished Product |
| Intended consumer | Commercial |
| Production process | Closed Production |
| Business models | B2C |
| Product categories | Medical Treatment |
| Biotech components | Enzyme |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Known funding amount | $200,000,000 USD |
| Country of production | USA |
| Country of distribution | USA |
| Trading symbol | HALO |
| Trading exchange | NASDAQ |
| Notes | Halozyme and Intrexon |